Find where trials recruit and how many sites they use
Feasibility work starts with comparable trials: how many sites, which countries, what enrollment, and why similar trials stopped. Trialtide has those columns for every registered study.
How CROs teams use Trialtide
- Filter comparable trials by condition, phase and intervention type.
- Compare site counts and countries to size a site plan.
- Count stop reasons (low enrollment, funding) among comparable trials to flag risk.
Site counts and countries come from the registry location lists; contact details are not included.
Industry phase 3 trials recruiting now, most sites first (build of 24 Sep 2026, registry data 23 Sep)
| NCT ID | Lead sponsor | Condition | Enrolling | Sites | Primary completion |
|---|---|---|---|---|---|
| NCT07000357 | AstraZeneca | Cardiovascular disease | 15,100 | 1,452 | 2029-10-26 |
| NCT07181109 | Alnylam Pharmaceuticals | Hypertension | 11,000 | 1,153 | 2030-09-23 |
| NCT07064473 | Boehringer Ingelheim | Type 2 diabetes | 11,800 | 1,143 | 2029-12-14 |
| NCT06677060 | AstraZeneca | Heart failure | 11,300 | 957 | 2029-12-17 |
| NCT07567001 | Novo Nordisk A/S | Obesity; heart failure | 5,610 | 838 | 2029-07-23 |
Source: Trialtide studies table, build of 24 Sep 2026 (products/trialtide/store/listing.json; HF dataset CyberMax-tools/trialtide-clinicaltrials-registry). Source: ClinicalTrials.gov (US National Library of Medicine). Not medical advice.
FAQ
Why not scrape it ourselves?
You can; the registry is public. Trialtide saves the paging and flattening and is free.
Can we use it for client work?
Yes. If procurement needs paperwork, the licence is $49/year for up to 10 people.
Trialtide: full guide with prices and alternatives · All use cases · Store